ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) was the target of a significant growth in short interest in September. As of September 15th, there was short interest totalling 9,200 shares, a growth of 5.7% from the August 31st total of 8,700 shares. Based on an average daily volume of 13,500 shares, the days-to-cover ratio is currently 0.7 days.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Toth Financial Advisory Corp raised its stake in shares of ProShares Ultra Nasdaq Biotechnology by 132.3% during the first quarter. Toth Financial Advisory Corp now owns 26,111 shares of the exchange traded fund’s stock worth $1,502,000 after acquiring an additional 14,870 shares in the last quarter. Clarity Capital Partners LLC purchased a new position in shares of ProShares Ultra Nasdaq Biotechnology during the fourth quarter worth approximately $201,000. Texas Capital Bank Wealth Management Services Inc purchased a new position in shares of ProShares Ultra Nasdaq Biotechnology during the first quarter worth approximately $288,000. Finally, Westwood Wealth Management purchased a new position in shares of ProShares Ultra Nasdaq Biotechnology during the first quarter worth approximately $575,000.

ProShares Ultra Nasdaq Biotechnology Price Performance

BIB stock opened at $63.10 on Wednesday. ProShares Ultra Nasdaq Biotechnology has a one year low of $40.10 and a one year high of $69.56. The company’s 50 day moving average price is $65.02 and its two-hundred day moving average price is $59.76.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The firm also recently declared a dividend, which will be paid on Wednesday, October 2nd. Shareholders of record on Wednesday, September 25th will be paid a dividend of $0.1528 per share. The ex-dividend date is Wednesday, September 25th. This is an increase from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.04.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.